Clinical pharmacodynamic effects of the growth hormone receptor antagonist pegvisomant: implications for cancer therapy (Q79750183)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 February 2007
edit
Language Label Description Also known as
English
Clinical pharmacodynamic effects of the growth hormone receptor antagonist pegvisomant: implications for cancer therapy
scientific article published on 01 February 2007

    Statements

    Clinical pharmacodynamic effects of the growth hormone receptor antagonist pegvisomant: implications for cancer therapy (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit